Table 4 Self-reported medication side effects of patients (N = 423)* according to treatment type
| Â | FGA1 | SGA2 | ||
|---|---|---|---|---|
| Â | men | women | men | women |
Parkinson symptoms | 17% | 15.6% | 3.8% | 11.6% |
dyskinetic/dystonic symptoms | 35.8% | 31.3% | 9.4% | 9.7% |
akathisia | 22.6% | 12.5% | 6% | 6.8% |
hyperprolactinaemia | - | - | - | 1.9% |
hormonal dysfunctions (gynecomastia, absence/changes of menorrhea) | - | 9.4% | - | 5.8% |
sexual dysfunction | 7.5% | - | 10.3% | - |
vertigo (incl. hypotonia) | 5.7% | 12.5% | 5.1% | 8.7% |
weight gain | 9.4% | 18.7% | 38.3% | 39.8% |
diabetes mellitus | - | - | 0.4% | - |
sialorrhea ('drooling') | - | - | 20.4% | 6.8% |
skin abnormalities, loss of hair | 1.9% | - | 1.7% | 5.8% |
gastrointestinal symptoms | 1.9% | 6.3% | 5.9% | 7.8% |
hyperhidrosis | - | - | 2.6% | - |
psychological symptoms (loss of concentration, no drive, tiredness) | 33.9% | 28.1% | 44.2% | 31.1% |
cardiovascular symptoms (tachycardia, hypertension) | - | - | 1.3% | 1.9% |
impaired vision | - | - | 1.7% | 3.9% |
dry mouth | 5.7% | 9.4% | 5.1% | 4.9% |
urinary retention | - | 3.1% | 1.3% | - |
number of patients who reported side effects | 53 | 32 | 235 | 103 |